Opko Health amends note purchase deal, issues USD 125 million additional senior secured notes

PUBT · 1d ago
Opko Health amends note purchase deal, issues USD 125 million additional senior secured notes
  • Opko Health amended a July 17, 2024 note purchase agreement on Aug. 13, 2026, issuing USD 125 million of additional senior secured notes.
  • Notes mature July 17, 2044; interest set at 3-month SOFR with a 4% floor, then 7.5% per year.
  • Quarterly interest tied to EirGen profit-share receipts from Pfizer; shortfalls covered first by mazdutide royalties from China sales.
  • Security package includes EirGen royalty interests; mazdutide payment support capped at USD 187.5 million, with excess applied to principal.
  • OPKO Biologics, EirGen guaranteed obligations; amendment adds customary negative covenants, financial covenants, default triggers including insolvency and cross-defaults.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-352370), on August 14, 2026, and is solely responsible for the information contained therein.